Search

everythinglearnresearchcommunity

for

Search:↓

Alefacept does not effectively treat severe alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A man lost all his hair as a rare side effect after hepatitis C treatment.

The review concluded that restrictions on people with HIV/AIDS often violated their rights without proven effectiveness in stopping the virus, highlighting education as the best control method.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

The monkeys' skin infection was cured in eight weeks using oral terbinafine, topical washes, and disinfectant fogging.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Minoxidil combined with ATRA boosts hair growth better than minoxidil alone.

Finasteride was successfully synthesized from Pregnadienolone acetate.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

A new method was developed to make finasteride for treating hair loss.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.